Clarkston Capital Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-143,433
Closed -$9.11M 132
2015
Q3
$9.11M Buy
143,433
+1,820
+1% +$131K 0.83% 45
2015
Q2
$9.96M Buy
141,613
+19,441
+16% +$1.44M 1.02% 42
2015
Q1
$9.69M Buy
122,172
+13,487
+12% +$995K 1.07% 37
2014
Q4
$6.92M Buy
108,685
+2,025
+2% +$127K 1.05% 32
2014
Q3
$6.37M Buy
106,660
+6,565
+7% +$376K 1.1% 30
2014
Q2
$5.36M Sell
100,095
-1,890
-2% -$104K 0.99% 34
2014
Q1
$6.15M Buy
101,985
+45,635
+81% +$2.66M 1.23% 28
2013
Q4
$2.99M Buy
56,350
+15,125
+37% +$760K 1.16% 29
2013
Q3
$1.91M Buy
41,225
+8,220
+25% +$377K 0.92% 36
2013
Q2
$1.35M Buy
+33,005
New +$1.41M 0.75% 41

Other funds holding CRL